Category Not assigned.—There are no available data on VRAYLAR use in pregnant women to inform any drug-associated risks for birth defects or miscarriage.
It is not known if cariprazine is excreted in breast milk.
All atypicals may increase mortality in elderly patients by 1.7 times greater than placebo.
No dosage adjustment necessary
Mild to moderate impairment: No dosage adjustment necessary; Severe impairment: Use not recommended